| Product | Code | ||
|---|---|---|---|
| CTNNB1 (N-term) | AP19561a | 400 µl |
Contact us |
| GSTT2 Antibody(Center) | AP19567c | 400 µl |
Contact us |
| Mut-16 Antibody (N-term) | AP1960a | 400 µl |
Contact us |
| Mut-16 Antibody (Center) | AP1960c | 400 µl |
Contact us |
| Gfl-1 Antibody (N-term) | AP1963a | 400 µl |
Contact us |
| Gfl-1 Antibody (C-term) | AP1963b | 400 µl |
Contact us |
| Rde-1 Antibody (Center) | AP1964c | 400 µl |
Contact us |
| Rsd-2 Antibody (N-term) | AP1966b | 400 µl |
Contact us |
| Rsd-2 Antibody (C-term Q1003) | AP1966e | 400 µl |
Contact us |
| LOC375295 (N-term) | AP19677a | 400 µl |
Contact us |
| Rde-4 Antibody (N-term) | AP1969a | 400 µl |
Contact us |
| Rde-4 Antibody (C-term) | AP1969b | 400 µl |
Contact us |
Akron Biotech
To maintain a leading industry position, Akron is constantly adapting and responding to customers’ changing needs. At Akron Biotech, we are not simply a reagent distributor. We form a relationship, furnishing clients with comprehensive solutions to meet their specific needs. This means we provide regulation-approved raw materials (USP, EP, and JP grades) and biological reagents, from research grade to GMP grade. Furthermore, our products are supported by expert services that ensure regulatory compliance and a shorter time-to-market. Akron differentiates itself on its quality, consistency, and expertise. We’re well placed to grow significantly in a rapidly expanding market. As a global supplier, Akron manufactures and distributes components and raw materials for cell therapy discovery, development, and commercialization, meeting the industry’s needs worldwide. Our company’s unique business model emphasizes flexibility, quality, and unparalleled service—from research and development through clinical trial, market authorization, and commercial product.
More information?Contact Us by e-mail info@divbio.eu
